Cue Biopharma, Inc. (CUE) vs Sionna Therapeutics, Inc. (SION)

Cue Biopharma, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. Cue Biopharma, Inc. and Sionna Therapeutics, Inc. are of similar size ($241.9M and $238.6M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −435.8%) and the lower return on invested capital (−125.0% vs 0.00%). Across the 12 metrics below, Sionna Therapeutics, Inc. leads on 9 and Cue Biopharma, Inc. on 3.

Valuation

Metric CUE SION Biotechnology median
P/E n/m n/m 7.88
P/S 5.29 n/m 11.47
P/B 86.22 0.89 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.87 n/m 10.73
Earnings yield (86.03%) (41.68%) (28.84%)
Free cash flow yield (25.17%) (32.31%) (23.03%)

Profitability

Metric CUE SION Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (262.03%) 0.00% 0.00%
Net margin (435.83%) 0.00% 0.00%
Free cash flow margin (133.13%) 0.00% 0.00%
Return on equity (1,603.48%) (32.34%) (57.72%)
Return on assets (459.60%) (30.66%) (49.22%)
Return on invested capital 0.00% (125.00%) 0.00%

Growth

Metric CUE SION Biotechnology median
Revenue growth (TTM) 354.37% — 5.64%
EPS growth (last fiscal year) 61.11% 88.24% —
Revenue growth, 5-year CAGR 54.16% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CUE SION Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 20.05 4.73
Net debt to EBITDA 1.10 2.58 0.96

Dividend

Metric CUE SION Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CUE SION Biotechnology median
Market cap 238.64m 241.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack